Cargando…
VpreB surrogate light chain expression in B-lineage ALL: a report from the Children’s Oncology Group
Immunotherapies directed against B-cell surface markers have been a common developmental strategy to treat B-cell malignancies. The immunoglobulin heavy chain surrogate light chain (SLC), comprising the VpreB1 (CD179a) and Lamda5 (CD179b) subunits, is expressed on pro- and pre-B cells, where it gove...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791581/ https://www.ncbi.nlm.nih.gov/pubmed/34662891 http://dx.doi.org/10.1182/bloodadvances.2021005245 |